In a filing, Guardant Health Inc revealed its Officer Eltoukhy Helmy acquired Company’s shares for reported $17.84 million on Sep 09 ’25. In the deal valued at $59.45 per share,300,000 shares were bought.
Then, Joyce Meghan V. sold 100 shares, generating $6,584 in total proceeds. Upon selling the shares at $65.84, the Director now owns 11,183 shares.
Before that, Joyce Meghan V. bought 100 shares. Guardant Health Inc shares valued at $6,584 were divested by the Director at a price of $65.84 per share.
Mizuho initiated its Guardant Health Inc [GH] rating to an Outperform in a research note published on April 10, 2025; the price target was $55. A number of analysts have revised their coverage, including Barclays’s analysts, who began to cover the stock in late January with a ‘”an Overweight”‘ rating. Guggenheim also remained covering GH and has increased its forecast on June 28, 2024 with a “Buy” recommendation from previously “Neutral” rating.
Price Performance Review of GH
On Tuesday, Guardant Health Inc [NASDAQ:GH] saw its stock fall -1.21% to $59.44. Over the last five days, the stock has lost -10.63%. Guardant Health Inc shares have risen nearly 144.31% since the year began. Nevertheless, the stocks have risen 94.57% over the past one year. While a 52-week high of $68.00 was reached on 09/02/25, a 52-week low of $20.14 was recorded on 01/02/25.
Levels Of Support And Resistance For GH Stock
The 24-hour chart illustrates a support level at 58.65, which if violated will result in even more drops to 57.87. On the upside, there is a resistance level at 60.29. A further resistance level may holdings at 61.15.
How much short interest is there in Guardant Health Inc?
A steep rise in short interest was recorded in Guardant Health Inc stocks on 2025-08-15, dropping by -1.39 million shares to a total of 8.19 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 9.58 million shares. There was a decline of -17.04%, which implies that there is a negative sentiment for the stock.
